A SIBO breath test measures gases after a glucose or lactulose drink. A hydrogen rise of at least 20 ppm by 90 minutes supports SIBO; methane of at least 10 ppm at any time supports intestinal methanogen overgrowth, but neither result alone establishes why you have symptoms.
- Hydrogen-positive pattern means a rise of at least 20 parts per million above baseline by 90 minutes under commonly used North American criteria.
- Methane-positive pattern means methane of at least 10 ppm at any sampling point, including baseline; it does not require a 10 ppm rise.
- Zarnu metanogēnu pārmērīga savairošanās is different from bacterial overgrowth because methane-producing organisms are archaea and may inhabit the small intestine or colon.
- Antibiotic preparation generally requires a 4-week interval before testing, unless the ordering clinician specifies otherwise.
- Fastēšanas sagatavošana usually lasts 8–12 hours after a laboratory-directed low-fermentation diet the preceding day.
- Glucose testing can miss more distal overgrowth because glucose is absorbed before reaching the entire small intestine.
- Lactulose testing is particularly vulnerable to false-positive interpretation when the drink reaches the colon before 90 minutes.
- Positive results support a clinical hypothesis; they do not measure symptom severity, identify a particular organism, or prove that antibiotics will help.
What does a SIBO breath test actually measure?
A SIBO breath test measures exhaled hydrogen and methane after a test sugar; it does not directly count organisms in the small intestine. The commonly used thresholds are a hydrogen rise of at least 20 ppm by 90 minutes or methane of at least 10 ppm at any time.
Microbial gases cross the intestinal lining, enter the circulation, and eventually appear in exhaled air. The laboratory records concentrations in parts per million, usually across multiple samples rather than one measurement; a concentration of 25 ppm says nothing reliable about the number of organisms present.
The North American Consensus established the familiar 20 ppm hydrogen rise within 90 minutes un 10 ppm methane criteria to improve consistency between laboratories, not to create an infallible anatomical diagnosis (Rezaie et al., 2017). Timing, substrate, preparation, and intestinal transit remain part of the interpretation.
A useful report should name the drink, document baseline gases, and show collection times—for example, 0, 20, 40, 60, 80, and 100 minutes. I would not make the same clinical decision from an isolated 'positive' label as from a complete curve with a documented preparation history.
Kantesti ir AI asins analīžu analizators that can help explain accompanying laboratory findings, but a breath result requires its own protocol-specific interpretation. Our organizācija un klīniskais tvērums distinguish blood-panel support from diagnosing intestinal overgrowth; neither a normal CBC nor a 60-second AI explanation establishes or excludes SIBO.
How is SIBO different from intestinal methanogen overgrowth?
SIBO refers to excessive bacteria in the small intestine, whereas intestinal methanogen overgrowth, or IMO, refers to excessive methane-producing archaea anywhere in the intestine. Methane of 10 ppm or more supports IMO under commonly used criteria, rather than proving methane-producing bacteria in the small bowel.
Methanogens are not bacteria. A prominent human intestinal methanogen, Methanobrevibacter smithii, uses hydrogen generated by other microbes; because methane production consumes hydrogen, testing only one gas can obscure the underlying pattern, even when methane reaches 10 ppm or more.
The 2020 American College of Gastroenterology guideline uses IMO terminology because methanogens may occupy the colon as well as the small intestine (Pimentel et al., 2020). A methane-positive breath test therefore cannot locate the overgrowth, and its interpretation should not depend on a small-bowel timing rule alone.
Constipation increases the clinical relevance of a methane-positive finding, but the relationship is not a one-way explanation. Someone passing stool every 4–5 days may have methanogen-associated slowing, medication-related constipation, a defecatory disorder, or several contributors together; a positive test should not stop that assessment.
A stool sequencing report and a hydrogen methane breath test answer different questions. Our discussion of microbiome testing limitations explains why finding 1 organism in stool does not establish its abundance in the small bowel—or make a breath curve unnecessary.
How do you read the hydrogen pattern?
A hydrogen-positive SIBO breath test generally requires hydrogen to rise at least 20 ppm above the baseline value by 90 minutes. The calculation uses a change from baseline, not an absolute hydrogen concentration of 20 ppm.
If baseline hydrogen is 4 ppm and the 80-minute result is 26 ppm, the increase is 22 ppm, meeting the commonly used criterion. If baseline is 14 ppm and the 80-minute result is 30 ppm, the increase is only 16 ppm; calling that positive because the final value exceeds 20 would be an arithmetic error.
The 90-minute boundary is a practical convention intended to separate earlier fermentation from later colonic fermentation. It is not a biological stopwatch: some people have faster transit, while delayed gastric emptying may postpone delivery of the drink to the small intestine.
A rise first appearing at 120 minutes does not meet the standard early hydrogen criterion, even if the peak is 70 ppm. With lactulose, a late rise commonly reflects fermentation in the colon; it does not independently establish where earlier symptoms originated.
Hydrogen-predominant patterns can accompany diarrhea, but stool appearance cannot confirm the gas source. Patients noticing nesagremota pārtika izkārnījumos should know that visible vegetable fragments and 3 loose stools a day may reflect rapid transit without demonstrating SIBO.
What does methane of 10 ppm or more mean?
Methane of at least 10 ppm at any sampled time, including the fasting baseline, meets the commonly used breath-test criterion for IMO. Unlike hydrogen, methane interpretation uses an absolute concentration, not a rise of 10 ppm above baseline.
A fasting methane value of 12 ppm can meet the criterion even if subsequent readings remain between 11 and 15 ppm. Conversely, a rise from 1 to 9 ppm does not meet the usual threshold, despite an eightfold increase; the absolute cutoff and the change tell different stories.
Methane positivity is associated with constipation, but it is not a constipation severity score. A reading of 40 ppm does not establish that symptoms are four times worse than those at 10 ppm, and there is no accepted methane concentration that constitutes a medical emergency by itself.
Methanogenesis can consume 4 hydrogen molecules for each methane molecule produced through the hydrogen-dependent pathway. That biochemical relationship helps explain why a low hydrogen curve is not automatically reassuring when methane is elevated; both gases belong in the same interpretation.
Record bowel frequency, straining, incomplete evacuation, and Bristol stool types alongside the report. Types 1–2, especially with substantial straining, may justify evaluation of constipation mechanisms that antibiotic treatment alone would not address.
Glucose versus lactulose: which breath test is better?
Glikoze is often preferred when avoiding transit-related false positives is the priority, while lactulose reaches more distal bowel but is more affected by colonic fermentation. Neither substrate is universally superior; common North American doses are 75 g glucose vai 10 g lactulose.
Glucose is absorbed in the proximal small intestine, which limits the opportunity for ordinary colonic microbes to generate an early signal. The trade-off is reduced sensitivity to more distal overgrowth; a negative 75 g glucose test cannot certify that every segment of the small intestine is unaffected.
Lactulose is poorly absorbed and normally reaches the colon, where fermentation is expected. If transit is fast enough for colonic arrival before 90 minūtes, the resulting hydrogen rise can satisfy a SIBO cutoff without demonstrating small-intestinal overgrowth.
International protocols differ: the 2022 European breath-test guideline recommends 50 g glucose, whereas the North American Consensus specifies 75 g (Hammer et al., 2022; Rezaie et al., 2017). Results obtained with different doses should not be treated as interchangeable simply because both reports say 'glucose breath test.'
The better choice depends on anatomy, transit concerns, and the question being asked—not which test is advertised as more comprehensive. Similar caution applies to DAO test interpretation: 1 abnormal digestive-related test does not automatically identify the mechanism responsible for bloating.
SIBO breath test preparation: diet, fasting and medicines
SIBO breath test preparation usually includes avoiding antibiotics for 4 nedēļu laikā, following the laboratory's restricted diet the preceding day, and fasting for 8–12 stundas. Laxatives and prokinetic medicines are often withheld for about 1 week if tolerated, but medication changes require clinician agreement.
The preparation diet aims to minimize residual fermentation, not to provide long-term digestive treatment. Many protocols allow plain rice, eggs, and unseasoned fish or poultry for 1 diena, while excluding beans, high-fiber foods, and certain dairy products; follow your laboratory's list rather than combining several internet menus.
Antibiotics can suppress fermentation and change the measured pattern, which is why a 4-week interval is commonly recommended (Rezaie et al., 2017). Recent colonoscopy preparation also matters: the European guideline recommends waiting at least 2 nedēļām after bowel cleansing before breath testing (Hammer et al., 2022).
There is no universally agreed probiotic stopping interval, and proton pump inhibitors do not routinely require discontinuation under North American consensus recommendations. Ask specifically about probiotics, magnesium laxatives, fiber supplements, and motility medicines; stopping a needed drug for 7 dienas may be inappropriate for someone with severe constipation.
Preparation should not become months of unnecessary dietary restriction. If celiac disease is also being considered, discuss gluten intake before testing, because eliminating gluten for several weeks can compromise celiac assessment even though the breath-test diet itself usually lasts only 1 day.
What happens during an at-home or clinic breath test?
A breath test begins with a fasting baseline sample, followed by the prescribed drink and repeated timed breath collections. Testing often lasts 2–3 stundas, with intervals commonly around 15–20 minutes, although the kit's exact schedule takes priority.
Collect the breath as instructed, usually using an end-expiratory sample rather than blowing an arbitrary amount of room air into the container. If the schedule says every 20 minūtes, write down actual collection times; a delayed sample should not quietly retain its intended timestamp.
Avoid smoking, vaping, vigorous exercise, food, and unapproved drinks during the testing period. Exercise and altered breathing can affect measured gas concentrations, while eating at 60 minūtēs introduces an additional fermentation stimulus that makes the original curve harder to interpret.
The drink can cause temporary bloating or loose stool, particularly with lactulose, but symptoms during the 2–3-hour test do not validate the result. People without SIBO can experience osmotic symptoms, and someone with a qualifying gas pattern may feel little during collection.
Fasting requires an individualized plan for people taking insulin or medicines that can cause hypoglycemia. Our guide to digestive symptoms around fasting explains related symptoms, but a prescribed 8–12-hour fast should never override a clinician's diabetes safety instructions.
Positive SIBO breath test results: three worked examples
A positive SIBO breath test should identify the qualifying gas, its value, its baseline, and its sampling time. Hydrogen requires a 20 ppm increase by 90 minutes; methane requires an absolute concentration of 10 ppm or more at any sampled point.
Consider an illustrative hydrogen curve: baseline 3 ppm, 40 minutes 8 ppm, and 80 minutes 25 ppm. The 22 ppm increase meets the usual hydrogen criterion, but confidence still depends on the substrate, transit risk, and whether preparation and sample collection were satisfactory.
A different illustrative report shows methane 14 ppm at baseline, then 13–18 ppm through the test, with hydrogen remaining below 8 ppm. That meets the methane criterion for IMO without an early hydrogen rise; describing it as 'negative because hydrogen is low' would miss the relevant finding.
A third report has hydrogen 2 ppm at baseline, 9 ppm at 80 minutes, and 48 ppm at 120 minutes after lactulose. The late rise does not meet the usual early criterion, and its size alone cannot distinguish expected colonic fermentation from clinically relevant small-bowel fermentation.
Numeric curves contain more information than a binary label. Our explanation of kvalitatīvi pret kvantitatīviem rezultātiem illustrates the same distinction: a result of 19 ppm above baseline and one of 55 ppm should not lose their timing and context merely because software assigns categories.
Why a positive result does not prove the cause of symptoms
A positive breath test identifies a gas pattern, not a proven explanation for bloating, pain, constipation, or diarrhea. Even a qualifying 20 ppm hydrogen rise can be misleading when rapid transit, altered anatomy, or poor preparation changes where and when fermentation occurs.
The European guideline specifically emphasizes the risk of false-positive breath testing from rapid transit, particularly with lactulose (Hammer et al., 2022). A 90-minute cutoff cannot locate the drink in an individual patient unless transit is independently assessed; timing is a surrogate, not direct visualization.
Pretest probability changes how persuasive a positive result is. Previous small-bowel surgery, a blind loop, or a substantial motility disorder provides a more specific clinical context than isolated evening bloating for 2 nedēļām, although none of these features alone confirms overgrowth.
Symptom overlap is extensive: IBS, carbohydrate intolerance, celiac disease, constipation, and pelvic-floor dysfunction can all produce similar complaints. Even improvement during a 10–14-day antibiotic course does not definitively prove SIBO, because symptom fluctuations and effects on colonic microbes can contribute.
A borderline inflammatory stool result should not be explained away by a positive breath curve. Our guidance on robežlīnijas fekālo kalprotektīnu describes why values around a laboratory's threshold may need reassessment; the breath-test 20 ppm cutoff does not exclude intestinal inflammation.
Can a negative, flat or high-baseline test be misleading?
A negative breath test does not exclude every form of intestinal overgrowth, and a high fasting hydrogen value is not automatically diagnostic. Baseline hydrogen above 20 ppm often raises preparation or interpretation questions; a flat hydrogen-and-methane curve also requires context.
Recent antibiotics, incomplete drink ingestion, missed samples, or delayed gastric emptying can blunt or postpone a response. A glucose test also may miss distal fermentation, so a negative 75 g test should be weighed against the clinical question rather than interpreted as a universal all-clear.
A fasting hydrogen value of 28 ppm may reflect residual fermentation, inadequate preparation, oral contribution, or another unresolved factor. Depending on the laboratory's protocol, clinicians may proceed cautiously, classify the study as difficult to interpret, or repeat it; baseline elevation alone is not the standard 20 ppm rise.
Hydrogen sulfide production is one possible explanation for low hydrogen in some patients, but a flat 2-gas test does not diagnose hydrogen sulfide overproduction. Additional gas assays exist, yet thresholds and clinical applications are less standardized than the conventional hydrogen and methane criteria.
Kantesti ir AI asins analīžu rezultātu platforma that should keep measurement quality separate from disease interpretation. Our validation and clinical safeguards explain that principle; for breath testing, check whether the laboratory assesses sample dilution using carbon dioxide or oxygen before trusting a surprising 0 ppm lasīšanu.
Which symptoms need evaluation beyond breath testing?
Unintentional weight loss, gastrointestinal bleeding, persistent vomiting, fever, and nighttime diarrhea warrant evaluation beyond a breath test. A positive result—even hydrogen rising 40 ppm by 80 minutes—does not rule out inflammatory, structural, pancreatic, or other clinically significant disease.
Inflammatory stool markers answer a different question from fermentation testing. Our comparison of kalprotektīna un laktoperoksidāzes explains their role; diarrhea that repeatedly wakes someone at 2:00. deserves assessment even when a breath curve already carries a positive label.
Greasy stools, weight loss, and difficulty maintaining nutrition may justify evaluation for fat malabsorption or pancreatic insufficiency. A zemam fekāliju elastāzes rezultātam zem 200 µg/g needs context, especially if collected from watery stool, which can dilute the concentration.
Black tarry stool, substantial red bleeding, fainting, or severe progressive abdominal pain should not wait for an elective breath test. Our guide to asins caurejas steidzamību distinguishes warning patterns; even 1 episode of suspected melena can require prompt assessment.
A constipation-dominant presentation also needs a medication and evacuation history. Someone with 2 bowel movements weekly, pronounced straining, and incomplete emptying may need targeted constipation or pelvic-floor management regardless of methane positivity; escalating antibiotics alone can miss the more treatable mechanism.
Can blood tests support a SIBO assessment?
Blood tests cannot diagnose SIBO, but they can identify anemia, nutrient deficiencies, inflammation, or alternative contributors to symptoms. A vitamin B12 result of 180 pg/ml, for example, warrants its own assessment and does not establish that intestinal overgrowth caused the deficiency.
Some intestinal bacteria can compete for vitamin B12, but low B12 also occurs with limited intake, pernicious anemia, medicines, and other absorption problems. Our B12 robežvērtības rezultāta interpretācija explains why a result around 200–300 pg/mL may need additional assessment rather than an assumed SIBO explanation.
Iron deficiency deserves an independent search for dietary, menstrual, gastrointestinal, and absorption-related causes. Our discussion of zems feritīns pirms anēmijas shows why ferritin below 15 ng/mL strongly supports depleted stores, while inflammation can make a less obviously low result harder to interpret.
Ferritin should be read with the CBC, transferrin saturation, symptoms, and relevant inflammation markers rather than used as a stand-alone digestive diagnosis. The pilnais dzelzs izmeklējumu ceļvedis explains why transferrin saturation below 20% can support iron restriction without identifying its cause.
Kantesti ir ar AI balstīts asins analīzes rīks that can organize these accompanying results and trends, typically generating an explanation in about 60 sekundēs. Our AI's role is to clarify the laboratory picture—not to infer a breath-test diagnosis from normal vitamin levels or recommend antibiotics from an isolated deficiency.
What should happen after a positive breath test?
After a positive result, clinicians should confirm test quality, assess whether the gas pattern fits the symptoms, and address underlying contributors before choosing treatment. A hydrogen rise of 20 ppm or methane of 10 ppm is a decision input, not an automatic antibiotic prescription.
The 2020 ACG guideline suggests antibiotics for symptomatic SIBO but acknowledges limitations in the evidence (Pimentel et al., 2020). Regimens vary by gas pattern and jurisdiction; a commonly used off-label rifaximin course is 550 mg three times daily for 14 days, but suitability and local prescribing rules require a treating clinician.
Methane-associated constipation sometimes prompts combination regimens, but those decisions involve additional risks and less certain evidence. Neomycin, for example, can cause kidney and hearing toxicity; a methane value of 15 ppm is not a reason to copy a combination prescription found online.
Repeated antibiotic exposure can cause adverse effects and complicate later assessment. Our guide to C. difficile result interpretation explains a separate diagnostic problem that may arise with diarrhea; 3 or more unformed stools in 24 hours after antibiotics warrants clinical consideration rather than assuming recurrent SIBO.
Follow-up should prioritize changes in the symptoms that mattered before treatment: bowel frequency, meal tolerance, pain, and nutrition. Choose 2–3 specific goals before starting, and reconsider alternative causes if those goals do not improve; a lower gas peak without meaningful clinical benefit is not the whole outcome.
Questions to ask your clinician and research context
Bring the complete curve, substrate dose, preparation history, and medication list to your follow-up appointment. As of 2026. gada 16. oktobris, this explanation draws on the 2017 North American Consensus, 2020 ACG guideline, and 2022 European guideline rather than assuming every laboratory uses identical criteria.
Ask 4 practical questions: which criterion did I meet, could transit or preparation explain it, what other causes remain plausible, and what outcome will define treatment success? My approach as Tomass Kleins, medicīnas doktors, is to separate the measured finding from the diagnosis and then from the treatment decision.
Medical communication should make uncertainty explicit without leaving patients directionless. The medicīnas konsultatīvā padome un mūsu medicīniskā satura standarti provide organizational context; a 10 ppm methane result still requires your treating clinician's assessment rather than a content page's prescription.
Kantesti's 2 Figshare publications listed below concern AI-assisted triage engineering and technical benchmarking, including 50,000 interpreted reports un 100 000 sintētisku gadījumu in their respective titles. They are not SIBO diagnostic studies and do not validate glucose-versus-lactulose accuracy, breath-test cutoffs, or antibiotic selection.
The practical distinction is between 3 levels of evidence: consensus guidance for conducting a test, clinical evidence for diagnosing and treating a condition, and technical evidence about a software engine. Keeping those levels separate prevents an impressive benchmark from being mistaken for proof that a positive breath result explains your symptoms.
Bieži uzdotie jautājumi
Kas tiek uzskatīts par pozitīvu SIBO elptestu?
Bieži izmantots ūdeņraža kritērijs pozitīvam SIBO elptesta rezultātam ir vismaz 20 ppm pieaugums virs sākotnējā līmeņa 90 minūšu laikā pēc glikozes vai laktulozes lietošanas. Metāna līmenis vismaz 10 ppm jebkurā parauga ņemšanas laikā, tostarp sākotnējā līmenī, liecina par zarnu metanogēnu pāraugšanu, nevis pierāda baktēriju pāraugšanu tievajā zarnā. Rezultātu interpretāciju var ietekmēt sagatavošanās, paraugu savākšanas kvalitāte, substrāta deva un zarnu tranzīts. Pozitīvs gāzu profils pats par sevi nenosaka simptomu cēloni.
Is methane SIBO the same as intestinal methanogen overgrowth?
The preferred term for a methane-positive pattern is intestinal methanogen overgrowth, or IMO, because methane-producing organisms are archaea rather than bacteria. These organisms may inhabit the small intestine or colon, so the breath result does not localize them. Methane of at least 10 ppm at any sampled point meets the commonly used criterion. IMO is associated with constipation, but other constipation mechanisms may coexist.
Is glucose or lactulose better for SIBO testing?
Glucose breath testing is generally less vulnerable to early colonic fermentation, but it can miss more distal small-intestinal overgrowth because glucose is absorbed proximally. Lactulose reaches the colon and is more susceptible to false-positive interpretation when transit is rapid. Common North American protocols use 75 g glucose or 10 g lactulose, while the 2022 European guideline recommends 50 g glucose. Test selection should reflect the patient's anatomy, transit concerns, and the laboratory's protocol.
How do I prepare for a SIBO breath test?
Typical SIBO breath test preparation includes avoiding antibiotics for 4 weeks, following the laboratory's restricted diet the day before testing, and fasting for 8–12 hours. Laxatives and prokinetic medicines may be withheld for about 1 week if tolerated and agreed with the clinician. Probiotic instructions vary, and proton pump inhibitors do not routinely require discontinuation under North American consensus recommendations. People taking insulin or medicines that can cause hypoglycemia need an individualized fasting plan.
Can a SIBO breath test be falsely positive or falsely negative?
A SIBO breath test can be falsely positive when rapid transit allows lactulose to reach the colon before the usual 90-minute hydrogen cutoff. False negatives can occur with recent antibiotics, delayed substrate delivery, poor collection, or distal overgrowth missed by glucose testing. A fasting hydrogen value above 20 ppm may make interpretation difficult but is not automatically a positive result. Reviewing the complete curve and preparation history is more useful than relying on a positive or negative label alone.
Does a positive breath test mean I need antibiotics?
A positive breath test does not automatically mean antibiotics are necessary or likely to help. A hydrogen rise of at least 20 ppm by 90 minutes or methane of at least 10 ppm supports a clinical hypothesis that must be matched to symptoms and test quality. Clinicians should also assess underlying motility problems, altered anatomy, constipation mechanisms, and alternative diagnoses. Antibiotic choice and follow-up should be individualized rather than copied from a gas threshold.
Can blood tests diagnose SIBO?
Blood tests cannot diagnose SIBO, although they can identify anemia, nutrient deficiencies, or alternative contributors to digestive symptoms. Vitamin B12 around 200–300 pg/mL may require further assessment, and ferritin below 15 ng/mL strongly supports depleted iron stores. Neither finding establishes that intestinal overgrowth caused the abnormality. Normal nutritional blood results also do not exclude SIBO or intestinal methanogen overgrowth.
Iegūstiet AI vadītu asins analīžu analīzi jau šodien
Pievienojieties vairāk nekā 2 miljoniem lietotāju visā pasaulē, kuri uzticas Kantesti tūlītējai, precīzai laboratorijas analīžu interpretācijai. Augšupielādējiet savas asins analīzes rezultātus un dažu sekunžu laikā saņemiet visaptverošu 15,000+ biomarķieru interpretāciju.
📚 Atsauces pētniecības publikācijas
Kleins, T., Mičels, S., un Vēbers, H. (2026). Daudzvalodu AI palīdzība klīniskās lēmumu pieņemšanas atbalstā agrīnai hantavīrusa noteikšanai: projektēšana, inženierzinātņu validācija un reāllaika ieviešana vairāk nekā 50 000 interpretētu asins analīžu pārskatu gadījumā. Kantesti AI Medicīnas pētījumi.
Kleins, T., Mičels, S., un Vēbers, H. (2026). Iepriekš reģistrēts, uz rubrikām balstīts automatizēts tehniskais etalons Kantesti asins analīžu interpretācijas dzinējam 100 000 sintētisku testa gadījumu. Kantesti AI Medicīnas pētījumi.
📖 Ārējās medicīniskās atsauces
Hammer HF et al. (2022). European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus. United European Gastroenterology Journal.
⚕️ Medicīniskā atruna
Šis raksts ir paredzēts tikai izglītojošiem nolūkiem un nav medicīnisks padoms. Vienmēr konsultējieties ar kvalificētu veselības aprūpes speciālistu, lai pieņemtu lēmumus par diagnostiku un ārstēšanu.
E-E-A-T uzticēšanās signāli
Pieredze
Ārstu vadīta klīniskā laboratorijas interpretācijas darbplūsmu pārskatīšana.
Ekspertīze
Laboratorijas medicīnas fokuss uz to, kā biomarķieri uzvedas klīniskā kontekstā.
Autoritāte
Sagatavojis Dr. Thomas Klein, pārskatījusi Dr. Sarah Mitchell un prof. Dr. Hans Weber.
Uzticamība
Uz pierādījumiem balstīta interpretācija ar skaidriem turpmākās rīcības ceļiem, lai mazinātu trauksmi.